1 刘萍编译．乳腺癌治疗药-阿纳托唑．国外医学·合成药、生化药、制剂分册，1997，18(15)：274． 2 杨静华．乳腺癌治疗药——芳香化酶抑制剂类研究进展．中国新药杂志，1995，4(2)：6． 3 Goss PE，Tye LM．Anastrozole．Oncology Huntigt，1997，11(11)：1697． 4 Geisler J，King N，Dowsett M．et al．Influence of anastrozole (Arimidex)，a selective non-steroidal aromatase inhibitor，on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer．Br J Cancer，1996，74(8)：1286． 5 Yates RA，Dowsett M，Fisher GV，et al．Arimidex (EDl033)．Br J Cancer，1996，73(4)：543． 6 Blamey RW．The role of selective non-steroidal aromatase inhibitors in future treatment strategies．Oncology，1997，54(Suppl 2)：27． 7 Buzdar AU，Jones SE，Vogel CL et al．A phase Ⅲ trial comparing anatrozole (1 and l0 milligranns)，a potent and selective aromatase inhibitor，with megestrol acetate in postmenopausal women with advanced breast carcinmme．Cancer，1997，79(4)：730． 8 Jonat W，Howell A，Blomqrist C et al．A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer．Eur J Cancer，1996，32A(3)：404． 9 Jonat W．Clinical overview of anastrozole-a new selective oral aromataseinhibitor．Oncology，1997，54(Suppl 2)：15． 10 徐兵河，冯奉仪．新一代芳香化酶抑制剂-瑞宁得．国外医学,1998，25(6)：3． 11 Roseman BJ，Buzdar AU，Sihgletary SE．Use of Aromatase inhibitors in postmenopausal women with advanced breast cancer．J Surg Oncol，1997，66(3)：215．